Detalles de la búsqueda
1.
Safety and immunogenicity of a 4-component GMMA-based Shigella vaccine in healthy European adults: Stage 1 of a randomized, controlled phase I/II clinical trial.
J Infect Dis
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38853614
2.
Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4-6 Years After a First Dose: Results From a Phase 2 Trial.
Clin Infect Dis
; 70(12): 2570-2579, 2020 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31394574
3.
Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine.
Vaccines (Basel)
; 11(2)2023 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851245
4.
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine.
Front Immunol
; 13: 1021500, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275772
5.
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination.
NPJ Vaccines
; 5: 29, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32219001
6.
Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study.
Vaccine
; 37(20): 2694-2703, 2019 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30987852
7.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trial.
Vaccine
; 35(46): 6321-6328, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28987445
8.
A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women.
Vaccine
; 34(15): 1786-91, 2016 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26928074
9.
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.
Vaccine
; 32(50): 6838-46, 2014 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24607003
10.
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.
PLoS One
; 8(2): e55438, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23437055
11.
Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine.
Clin Vaccine Immunol
; 18(9): 1510-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21734063
12.
Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.
Clin Vaccine Immunol
; 18(5): 835-43, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450978
13.
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
Vaccine
; 28(3): 849-57, 2010 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19835828
Resultados
1 -
13
de 13
1
Próxima >
>>